Micro Current Neuromodulation in the Management of Dry Age-Related Macular Degeneration - A Pilot Study

Abstract

Purpose: : To describe short-term outcomes of a pilot study to evaluate safety and efficacy of micro-current neuromodulation (MCN) in the management of dry age-related macular degeneration(DAMD).

Results: : Twentypatients(38eyes)were included in the study.Mean age was 65.5 years (range 52-78yrs).Male preponderance was seen 13 (65%).Stage I disease was seen in 8 eyes, 11were Stage II and 19 were Stage III. Baseline mean visual acuity(LogMAR-letters read) was 39,42 and 19 letters for stages I, II and III eyes respectively.At 6 months, this changed to 49(p=0.006) 44 (p=0.223) and 23 (p=0.036) respectively.Contrast sensitivity at 6 months, showed a mean improvement of >1grating acuity at high (1.5cpd) and medium (3cpd)contrast grating-acuity for stage III eyes, while the low contrast grating acuity showed >1 grating acuity improvement in stage I eyes.Minor adverse events including headaches and burning sensation around the eyelids were noted during the study period.

Conclusions: : To describe short-term outcomes of a pilot study to evaluate safety and efficacy of micro-current neuromodulation (MCN) in the management of dry age-related macular degeneration(DAMD).

Keywords: age-related macular degeneration